JAK2 and chronic myelogenous leukemia, BCR-ABL1 positive: To corroborate the findings of this study and provide evidence that Crizotinib-induced chemoresistance in CML cells is dependent on HIF1α, the mutant HIF1α was overexpressed in K562 cell lines while silencing JAK2.